[Federal Register: September 19, 2007 (Volume 72, Number 181)]
[Notices]
[Page 53606]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19se07-120]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 24, 2007, Research
Triangle Institute, Kenneth H. Davis Jr., Hermann Building, P.O. Box
12194, East Institute Drive, Research Triangle, North Carolina 27709,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Cocaine (9041)............................. II
------------------------------------------------------------------------
The Institute will manufacture small quantities of cocaine and
marihuana derivatives for use by their customers in analytical kits,
reagents, and reference standards as directed by NIDA.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 2401
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed
no later than November 19, 2007.
Dated: September 12, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-18446 Filed 9-18-07; 8:45 am]
BILLING CODE 4410-09-P